No Data
No Data
Ironwood Pharma (IRWD) Gets a Buy From JMP Securities
Ironwood Pharmaceuticals: Hold Rating Amidst Financial and Market Headwinds
Express News | Ironwood Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Financial Results and Revised Its FY24 Guidance
Ironwood Pharmaceuticals Non-GAAP EPS of $0.00 Misses by $0.14, Revenue of $94.4M Misses by $12.6M
Express News | Ironwood Pharmaceuticals Inc: Sees 2024 Total Revenue $350 Mln - $375 Mln
Earnings Flash (IRWD) IRONWOOD PHARMACEUTICALS Reports Q2 Revenue $94.4M
No Data
Jimmy1819 : have you been investing professionally or as a hobby?